MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
MD Anderson 2020 Updates on Biomarkers in Melanoma: Can ctDNA Be Used as a Tissue Surrogate for Mutation Detection? Does the Concentration of ctDNA Increase With Progression?
FEATURING
Anthony Lucci
- 82 views
- December 1, 2020
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
MD Anderson 2020 Updates on Melanoma Staging & Diagnosis: Microscopic Examination, Breslow Thickness/Depth, Clark Level, Ulceration, Mitotic Index, Lymphovascular/Perineural Invasion, TIL, SLN, Regression
FEATURING
Victor Prieto
- 209 views
- November 19, 2020
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
MD Anderson 2020 Updates on Surgical Management of Melanoma: Does Complete Lymph Node Dissection Improve DMFS vs. No Dissection in SLN+ Disease? How Often Do We Use HILP/ILI vs. Systemic Therapy?
FEATURING
Jeff Gershenwald
- 105 views
- November 19, 2020
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
2020 Updates on Adjuvant Therapy in Advanced Stage Melanoma: What Is the Effect of Ipi on RFS and Toxicity? Does Nivo improve RFS? Are There DMFS Benefits With Pembro vs. Placebo?
FEATURING
Rodabe Amaria
- 184 views
- November 19, 2020
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
MD Anderson 2020 Updates on Oncolytic IO for Advanced Melanoma: Is T-VEC Mono Effective in Resectable Disease? Does T-VEC + CPI Combo Work? Which Options Are Considered in Neoadjuvant and PD-1 Resistant Setting?
FEATURING
Merrick Ross
- 150 views
- November 19, 2020
- 1
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
MD Anderson 2020 Update on IO for Metastatic Melanoma: What Is the 5-Year OS With Single-Agent PD-1 & PD-/CTLA-4 Agents? Which Options to Consider After Progression on PD-1(+/- Ipi)?
FEATURING
Michael Davies
- 247 views
- November 19, 2020
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
MD Anderson 2020 Updates on Advanced Melanoma: Ipi/Pembro Mono and Ipi+Nivo PFS/OS Data for CNS Metastases, Intracranial Response With Dabrafenib+Trametinib in BRAF V600-Mutated Disease
FEATURING
Isabella Glitza-Oliva
- 109 views
- November 19, 2020
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
Neoadjuvant Treatments for Advanced CSCC
FEATURING
Neal Gross
- 236 views
- November 19, 2020
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
Management of Advanced CSCC: EMPOWER-CSCC-1 Study
FEATURING
Michael Migden
- 226 views
- November 19, 2020
